Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes.

Trial Profile

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Aug 2012

At a glance

  • Drugs ARRY 403 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Most Recent Events

    • 05 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Aug 2009 Primary and secondary endpoints have been met, according to an Array biopharma media release.
    • 11 Aug 2009 Positive top-line data announced in an Array Biopharma media release. Combined results of the single and multiple ascending-dose ARRY 403 studies will be reported at an upcoming scientific meeting during the first half of 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top